期刊文献+

纤维蛋白原与支架内再狭窄的相关性研究

The Relation among Serum Fibrinogen and In-stent Restenosis
暂未订购
导出
摘要 目的探讨纤维蛋白原(fibrinogen,FIB)与支架内再狭窄的相关性。方法选择2007年8月~2009年12月曾在我院植入火鸟支架(firebird各型药物支架,上海微创公司生产)并于3~12个月内完成了冠脉造影复查的64例患者为研究对象,根据有无支架内再狭窄分为再狭窄组(n=13)和无再狭窄组(n=51)。术前检测血清FIB、甘油三酯(tfiglycende,TG)、总胆固醇(total cholesterol,TC)、高密度脂蛋白酯(high density lipoprotein cholesterol,HDL—c)、低密度脂蛋白酯(low—density lipoprotein cholesterol,LDL—c)、载脂蛋白A1(apolipoprotein A1,ApoA1)、载脂蛋白B(apolipoprotein B.ApoB)。比较FIB在两组间有无差异。并且对FIB与再狭窄进行偏相关分析及多元逐步回归分析。结果1.FIB在术后支架内再狭窄组明显高于无再狭窄组(P〈0.001)。2.多元线性回归分析发现,FIB与再狭窄的相关性是除TC外的第二个最强指标(p〈0.001)。结论FIB与支架内再狭窄相关。 Objectives: To explores the relationship between serum fibrinogen (FIB) and in-stent restenosis by using coronary angiography and measuring the serum FIB .Methods: In the study 64 patients with CHD and implanting stent were selected in the department of cardiology in affliatted hospital from August, 2007 to December , 2009.After admission all candidates underwent coronary angiography and their serum FIB were determined. According to the result of coronary angiography all the subjects were divided into 2 groups: in-stent restenosis group (n=13) and no in-stent restenosis group (n=51) . the study also shows the intensity of the dependability by multivariate regression .Results: 1 The levels of serum FIB in ISR group is higher than that in no in-stent restenosis (ISR) group. 2 The multivariate regression analysis showed that the serum FIB is correlated with CSS , the amount of stenosis vessel and ISR. Conclusions: The levels of FIB is related to ISR.
出处 《中国保健营养(临床医学学刊)》 2010年第8期15-18,共4页 China Health Care Nutrtion
关键词 冠心病 冠状动脉造影 纤维蛋白原 血脂 支架内再狭窄 Coronary heart disease Coronary angiography Plasma lioids Fibrinogen In-stent restenosis
  • 相关文献

参考文献2

二级参考文献9

  • 1[1]Carrozza JP, Kuntz RE, Levine VJ, et al. Angiographic and- and diniealoutcome of intracoronsry stenting:immediate and long - term results froma large single-center experience. J Am Coll Cardiol, 1992;20:328
  • 2[2]Wilox JN. Thrombin and other potential mechanisms underlyingrestenosis. Circulation, 1995; 92: 2995
  • 3[3]Lafout A, Guzman LA, Whitlow PL, et al. Restenosis after experi-mental angioplasty. Intimal, medial, and adventitial changes associat-ed with constrictive remodeling. Circ Res, 1995;76:996
  • 4[4]Lefkovits J, Topol EJ. Pharmacological approaches for the profanationof restenosis after percutaneous coronary intervention. Prog CardiovascDis, 1997;40(2):141
  • 5[5]Curlek A,Dagalp Z,Oral D, et al. Restenosis after transluminal coro-nary angioplasty: a risk factor analysis. J Cardiovase Risk,1995;2:51
  • 6[6]David H, Kerk NG, Diane EG, et al. Effect of smoking status on long-term outcome after successful percutaneous coronary revasculariza-tion. N Eng J Med, 1997;336:755
  • 7[7]Violaris AG, Melkert R, Herrman JPR, et al. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coro-nary angioplasty. A quantitative angiographic analysis. Circulation,1996; 93: 889
  • 8[8]Montalescot G, Ankri A, Vicaut E, et al. Fibrinogen after coronaryangioplasty as a risk factor for restenosis. Circulation, 1995; 92: 31
  • 9[9]Bertrand ME, Mcfadden EP, Fruchart JC, et al. Effect of provastatinon angiographic restenosis after balloon angioplasty. J Am Coll Cardi-ol, 1997;30:863

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部